FN3 protein fragment containing two type III fibronectin domains from B. longum GT15 binds to human tumor necrosis factor alpha in vitro.


Journal

Anaerobe
ISSN: 1095-8274
Titre abrégé: Anaerobe
Pays: England
ID NLM: 9505216

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 24 02 2020
revised: 09 07 2020
accepted: 21 07 2020
pubmed: 11 8 2020
medline: 23 6 2021
entrez: 11 8 2020
Statut: ppublish

Résumé

Most species of the genus Bifidobacterium contain the gene cluster PFNA, which is presumably involved in the species-specific communication between bacteria and their hosts. The gene cluster PFNA consists of five genes including fn3, which codes for a protein containing two fibronectin type III domains. Each fibronectin domain contains sites similar to cytokine-binding sites of human receptors. Based on this finding we assumed that this protein would bind specifically to human cytokines in vitro. We cloned a fragment of the fn3 gene (1503 bp; 501 aa) containing two fibronectin domains, from the strain B. longum subsp. longum GT15. After cloning the fragment into the expression vector pET16b and expressing it in E. coli, the protein product was purified to a homogenous state for further analysis. Using the immunoferment method, we tested the purified fragment's ability to bind the following human cytokines: IL-1β, IL-6, IL-10, TNFα. We developed a sandwich ELISA system to detect any specific interactions between the purified protein and any of the studied cytokines. We found that the purified protein fragment only binds to TNFα.

Identifiants

pubmed: 32771620
pii: S1075-9964(20)30103-7
doi: 10.1016/j.anaerobe.2020.102247
pmc: PMC7409735
pii:
doi:

Substances chimiques

Bacterial Proteins 0
Cytokines 0
Fibronectins 0
Recombinant Proteins 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102247

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Références

EMBO J. 1998 Mar 16;17(6):1665-74
pubmed: 9501088
Cell Mol Life Sci. 2018 Jan;75(1):103-118
pubmed: 28983638
Microb Ecol. 2015 Oct;70(3):819-34
pubmed: 25894918
Virulence. 2017 Nov 17;8(8):1592-1601
pubmed: 28783440
FEBS Lett. 1995 Aug 28;371(1):65-8
pubmed: 7664886
Science. 2005 Jul 29;309(5735):774-7
pubmed: 16051797
Arch Microbiol. 2014 Feb;196(2):125-36
pubmed: 24395073
Proc Natl Acad Sci U S A. 1990 Sep;87(18):6934-8
pubmed: 2169613
mBio. 2016 Mar 15;7(2):e02046
pubmed: 26980835
Nutrients. 2017 May 19;9(5):
pubmed: 28534820
Nat Rev Microbiol. 2008 Feb;6(2):111-20
pubmed: 18197168
Adv Nutr. 2019 Jan 1;10(suppl_1):S49-S66
pubmed: 30721959
Front Microbiol. 2016 Aug 05;7:1220
pubmed: 27547201
Scientifica (Cairo). 2013;2013:361073
pubmed: 24381789
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Science. 1991 Oct 18;254(5030):430-2
pubmed: 1833820
Infect Immun. 1993 Mar;61(3):830-5
pubmed: 8381771
Appl Environ Microbiol. 2016 Apr 18;82(9):2676-2685
pubmed: 26921419
Nat Rev Immunol. 2019 May;19(5):305-323
pubmed: 30858494
Anaerobe. 2018 Jun;51:26-35
pubmed: 29534913
Virulence. 2017 Feb 17;8(2):115-134
pubmed: 27459270
Front Microbiol. 2019 Oct 15;10:2374
pubmed: 31681231
Nutrients. 2020 Feb 01;12(2):
pubmed: 32024101
Am J Respir Crit Care Med. 1999 Sep;160(3):961-7
pubmed: 10471625
Semin Immunopathol. 2017 Jul;39(5):529-539
pubmed: 28466096
Cell Mol Life Sci. 2014 Jan;71(2):183-203
pubmed: 23516017
J Immunol. 2016 Jul 1;197(1):11-8
pubmed: 27317733
Science. 2015 Jan 9;347(6218):170-5
pubmed: 25574022
Front Microbiol. 2016 Jun 15;7:925
pubmed: 27379055
Infect Immun. 1991 May;59(5):1853-6
pubmed: 2019445
J Dairy Sci. 1993 Apr;76(4):978-82
pubmed: 8486849
Sensors (Basel). 2009;9(9):6967-90
pubmed: 22399982
Gene. 1990 Nov 30;96(1):23-8
pubmed: 2265755
J Bacteriol. 2010 Jan;192(1):68-76
pubmed: 19880595
Clin Immunol. 2020 May;214:108393
pubmed: 32222466
Antonie Van Leeuwenhoek. 2006 Jul;90(1):69-91
pubmed: 16670965
Front Microbiol. 2016 Aug 03;7:1193
pubmed: 27536282

Auteurs

Ilya N Dyakov (IN)

I.I, Mechnikov Research Institute for Vaccines and Sera, Malyj Kazennyj Per., 5, Moscow, Russia, 105064.

Dilara A Mavletova (DA)

Vavilov Institute of General Genetics, Russian Academy of Sciences, Gubkina St., 3, Moscow, Russia, 119991.

Irina N Chernyshova (IN)

I.I, Mechnikov Research Institute for Vaccines and Sera, Malyj Kazennyj Per., 5, Moscow, Russia, 105064.

Nadezda A Snegireva (NA)

I.I, Mechnikov Research Institute for Vaccines and Sera, Malyj Kazennyj Per., 5, Moscow, Russia, 105064.

Marina V Gavrilova (MV)

I.I, Mechnikov Research Institute for Vaccines and Sera, Malyj Kazennyj Per., 5, Moscow, Russia, 105064.

Kristina K Bushkova (KK)

I.I, Mechnikov Research Institute for Vaccines and Sera, Malyj Kazennyj Per., 5, Moscow, Russia, 105064.

Marina S Dyachkova (MS)

Vavilov Institute of General Genetics, Russian Academy of Sciences, Gubkina St., 3, Moscow, Russia, 119991.

Maria G Alekseeva (MG)

Vavilov Institute of General Genetics, Russian Academy of Sciences, Gubkina St., 3, Moscow, Russia, 119991.

Valery N Danilenko (VN)

Vavilov Institute of General Genetics, Russian Academy of Sciences, Gubkina St., 3, Moscow, Russia, 119991; Peoples' Friendship University of Russia (RUDN University), Faculty of Ecology, International Institute for Strategic Development of Sectoral Economics, Miklukho-Maklaya St., 6, Moscow, Russia, 117198; Pharmabiotics Limited Liability Company, Bolshoy Boulevard, 42, Bldg. 1, 1238, Moscow, Russia, 121205. Electronic address: valerid@vigg.ru.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH